Hologic, Quest Diagnostics sales and marketing update

The partners entered a five-year, non-exclusive deal to allow Quest to offer a broader range of Hologic's Aptima diagnostic products and to co-develop and promote diagnostics to improve women's health. Hologic's Aptima products include FDA-approved assays for HPV, HPV genotyping, chlamydia, gonorrhea and Trichomonas vaginalis.

Quest already offers in the U.S. Hologic's Aptima HPV Assay, which is indicated in patients with atypical squamous cells of undetermined significance cervical cytology results to determine the need for a colposcopy referral or in women at least 30 years old in combination with cervical cytology to assess the presence or absence of high-risk HPV types. ...